Globally, chronic diseases such as diabetes, coronary heart disease, and cancer, as well as increasing health care spending, are primarily driving the growth of the global enteral nutrition market. According to the American Diabetes Association (ADA), long-term use of dietary supplements that contain diabetes-specific formulations can reduce persistent health issues, such as heart disease, and according to the National Center for Biotechnology Information (NCBI), enteral nutrients can help with heart failure (CHF). As reported by the Office for National Statistics, the United Kingdom spent US$ 239 on general fitness care in 2015. $92 billion of 2014's $248 billion was made up of $92 billion, which multiplied by 3.6%. In 2015, 150 billion dollars were spent. Health care spending in an area can make expensive medical services available to patients. Thus, the enteral nutrition market is expected to rise, considering that, according to NCBI, tube-fed patients incur a higher price than those without tubes. Geriatric patients make up the largest demographic of those who receive oral nutrition, even though all ages benefit from it. It is important for the growth of the enteral nutrition market that geriatric populations accept metabolic problems and eating disorders.
A problem affecting the growth of the enteral nutrition market is the dangers associated with patient security, as well as errors in feeding and medication administration. According to NCBI, the placement of a nasogastric tube is associated with many hazards, including gastrointestinal headaches, aspiration, mechanical headaches, and metabolic headaches.